SCHEMBL16311993

CC(=O)NC1C(O)[C@H](O[C@@H]2OC(CO[C@]3(C(=O)O)C[C@@H](O)[C@@H](C)C([C@H](O)[C@H](O)CO)O3)[C@H](O)[C@H](O)C2O)[C@H](CO)O[C@H]1OC1[C@@H](OCC2O[C@@H](O[C@@H]3C(CO)O[C@@H](O[C@@H]4C(CO[C@@H]5O[C@@H](C)[C@@H](O)C(O)C5O)O[C@@H](C)C(NC(C)=O)[C@H]4O)C(NC(C)=O)[C@H]3O)C(O)[C@@H](O[C@H]3OC(CO)[C@@H](O)C(O)C3O[C@@H]3OC(CO)[C@@H](O[C@@H]4OC(CO[C@]5(C(=O)O)C[C@@H](O)[C@@H](C)C([C@H](O)[C@H](O)CO)O5)[C@H](O)[C@H](O)C4O)[C@H](O)C3NC(C)=O)[C@@H]2O)OC(CO)[C@@H](O)[C@@H]1O

nearest known ligand 0.57

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	SIGLEC7	Q9Y286	6/20	0.57

▸	SELL	P14151	2/20	0.53

▸	SELP	P16109	2/20	0.53

▸	SELE	P16581	4/20	0.51

▸	MAG	P20916	6/20	0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL16311984	0.99	SIGLEC7 (0.56)	SIGLEC7SELLSELPSELEMAG
SCHEMBL16311987	0.99	SIGLEC7 (0.56)	SIGLEC7SELLSELPSELEMAG
SCHEMBL16312002	0.99	SIGLEC7 (0.56)	SIGLEC7SELLSELPSELEMAG
SCHEMBL16311983	0.96	SIGLEC7 (0.59)	SIGLEC7SELLSELPSELEMAG
SCHEMBL16311992	0.96	SIGLEC7 (0.57)	SIGLEC7SELLSELPSELEMAG
SCHEMBL16312001	0.95	SIGLEC7 (0.59)	SIGLEC7SELLSELPSELEMAG
SCHEMBL12451190	0.95	SIGLEC7 (0.57)	SIGLEC7SELLSELPSELEMAG
SCHEMBL17827374	0.95	SIGLEC7 (0.57)	SIGLEC7SELLSELPSELEMAG
SCHEMBL18193384	0.95	SIGLEC7 (0.55)	SIGLEC7SELLSELPSELEMAG
SCHEMBL18193383	0.95	SIGLEC7 (0.55)	SIGLEC7SELLSELPSELEMAG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20140369964-A1	GLYCOSYLATED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME	GLYTECH, INC. (JP)	2014-12-18	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20140369964-A1	GLYCOSYLATED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME	IFNG, IFNAR1, IAPP	SIGLEC7 20/4885SELL 337/4885SELP 577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.